On June 10, 2024, Anterior, the AI company built by clinicians to transform healthcare administration, announced the completion of a $20 million Series A funding round. The round was led by New Enterprise Associates (NEA), with participation from Sequoia Capital, Blue Lion Global, and Neo. Wilson Sonsini Goodrich & Rosati advised Anterior on the transaction.

Anterior is on a mission to unlock doctors and nurses from the administrative burden they experience. The company’s first objective is to make prior authorization invisible, like the seamless communication that occurs when a credit card is swiped. Anterior’s technology leverages generative AI to clinically reason, delivering value out of the box, unlike the predictive AI models that have emerged in previous years. The Series A funding will help Anterior accelerate its hiring and growth strategies, ensuring the company continues to recruit and retain world-class talent and that its technology remains cutting-edge.

The Wilson Sonsini team that advised Anterior on the transaction included Damien Weiss, Rob Broderick, and Michelle Mealer.

For more information, please see Anterior’s news release.